Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Neoadjuvant and Adjuvant Strategies [0.03%]
肌侵袭性膀胱癌围手术期免疫治疗：新辅助和辅助治疗策略的系统评价和meta分析
C V Suartz,I M T Huber,P H de S Brito et al.
C V Suartz et al.
Aims: To evaluate the efficacy and safety of the perioperative immunotherapy-based regimens. Materials and methods: A systematic search...
Authors' Reply: "Healthcare Systems Data to Improve the Efficiency of Clinical Trials Within the UK: A Prospectively Planned Comparison of Healthcare Systems Data and Trial-reported Outcomes Within the Add-Aspirin Cancer Clinical Trial" [0.03%]
作者回应：“利用英国医疗体系数据提高临床试验效率：在Add-阿司匹林癌症临床试验中前瞻性计划的医疗体系数据与试验报告结果比较”
A Macnair,D C Gilbert,R E Langley et al.
A Macnair et al.
A Vitiello,A Zovi
A Vitiello
Survival Outcomes Associated With Prolonged Pembrolizumab After Definitive Chemoradiation for Non-small Cell Lung Cancer [0.03%]
派姆单抗用于不可手术非小细胞肺癌根治性同期放化疗后的长期生存结局分析
A Homeniuk,A Syed,A Atrash
A Homeniuk
Aim: The optimal duration of pembrolizumab after definitive chemoradiation for non-small cell lung cancer remains uncertain in routine practice. Although prospective trials support immunotherapy-based strategies in locall...